Hernia patch lawsuits
Hernia Patch Litigation Court Will Hear Claims by Patients With Non-Recalled Hernia Mesh and Patch Devices Manufactured by Bard, Inc. and Davol, Inc.
The court assigned to oversee the nationwide hernia patch and mesh lawsuits will hear claims of patients with both recalled and non-recalled hernia mesh and patch devices.
Over the last few years a number of patients have brought hernia mesh patch lawsuits against C.R. Bard, Inc., and Davol, Inc. alleging that their hernia mesh patch devices were defective and caused injuries. A large number of the claims were brought after an FDA hernia patch recall including claims based on defects in hernia mesh patches non-recalled hernia mesh patch devices.
Hernia patch lawsuits from across the United States have now been consolidated into a single court for all pretrial proceedings. In a recent ruling the court clarified the scope of the consolidated proceedings to include both recalled and non-recalled devices.
The federal Multi-District Litigation court has announced that it will hear hernia mesh and patch lawsuits involving both recalled and non-recalled devices manufactured by C.R. Bard, Inc., and Davol, Inc., including the following;
-All nine (9) models of Bard ComposiX Kugel Hernia Patches (Product Codes 0010201 through 0010209);
-All other Davol hernia patches with PET rings, including the Bard Kugel Hernia Patch; Bard VentraleX Hernia Patch; Bard CK Parastomal Patch; and Bard Modified Kugel Patch; and
-Other Davol hernia meshes composed of layers of polypropylene and ePTFE, including the Bard Composix E/X Mesh.
Hernia patch lawyers at The Johnson Law Firm, a national law firm representing a large number of patients who have been injured by the recalled Bard Composix Kugel Hernia Mesh Patch are evaluating claims by patients with non-recalled hernia patch and mesh products manufactured by Davol, Inc. and C. R. Bard, Inc. Hernia patch lawsuit information, hernia patch class action information, hernia patch recall information and claims evaluations are available at no cost to affected patients at and toll free at 1-866-374-0338.